张波，男，1989年出生，中共党员，永利集团88304研究员。主要研究方向为大数据驱动的传染病及药物滥用预防与控制。“十三五”科技冬奥重点专项、“十四五”生物与信息融合重点专项任务负责人，主持国家自然科学青年基金、中国博士后科学基金等纵向课题。在The Lancet、The Lancet Infectious Diseases、The Lancet Regional Health – Western Pacific等期刊发表文章30余篇。担任JAMA Network Open、The Lancet Child & Adolescent Health、The Lancet Regional Health等多个期刊审稿人，兼任Scientific Reports编委、《环境卫生学杂志》青年编委。

【学习经历】

2007.09-2011.06 山东财经大学，计算机科学与技术系 学士

2013.09-2016.06 山东大学，软件工程系 硕士

2017.09-2021.01 北京大学，流行病与卫生统计学系 博士

【工作经历】

2011.08 - 2012.05 中国联通 网络工程师

2016.06 - 2016.12 国泰君安证券 数据分析师

2021.01 - 2023.06 北京大学 博士后

2023.08 – 至今 永利集团 研究员

【社会兼职】

JAMA Network Open、The Lancet Child & Adolescent Health、The Lancet Regional Health - Western Pacific、eClinicalMedicine、Emerging Microbes & Infections、International Journal of Drug Policy、Frontiers in Public Health、American Journal of Infection Control审稿人，Scientific Reports编委，《环境卫生学杂志》青年编委。

【科研课题】

1. 科技部，“十四五”国家重点研发计划“生物与信息融合（BT与IT融合）”重点专项，2022YFF1203204，病毒基因组未来变异演化预测与预警技术研发，2023/01-2025/12，在研，任务负责人。

2. 国家自然科学基金青年基金，72104008，大型体育赛事新冠疫情预警预测模型研究，2022/01-2023/12，结题，主持。

3. 中国博士后科学基金，2022M710250，大数据驱动的我国肺结核复发防控策略研究，2022/01-2022/12，结题，主持。

4. 科技部，国家重点研发计划“科技冬奥”重点专项，2021YFF0306001， 疫情风险及其外溢效应对冬奥会的影响与对策研究，2021/04-2022/06，结题，任务负责人。

5. 北京大学首都发展研究院，基于北京市吸毒人员全景数据集的毒情综合管理模式研究，2018/10-2019/03，结题，主持。

【学术论文】 ( # first author; * correspondence author)：

1. Zhang B#*, Qin S. Mental health at the forefront of women-centred health-care systems. Lancet. 2023 Aug 5;402(10400):445. doi: 10.1016/S0140-6736(23)00635-9

2. Zhang B#, Yan X, Li Y, Zhu H, Lu Z, Jia Z. Trends in Methamphetamine Use in the Mainland of China, 2006-2015. Frontiers in Public Health. 2022 Apr 28;10:852837. doi:10.3389/fpubh.2022.852837.

3. Zhang B#, Yan X, Li Y, Zhu H, Liu Z, Lu Z, Jia Z. Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study. Harm Reduction. 2021 Jun 12;18(1):63. doi: 10.1186/s12954-021-00511-6.

4. Zhang B#, Yan X, Li Y, Zhu H, Lu Z, Jia Z. Association between Drug Co-use Networks and HIV Infection: A Latent Profile Analysis in Chinese Mainland[J]. Fundamental Research. 2021 Sep 1;5;552-558. doi: 10.1016/j.fmre.2021.08.011

5. Zhang B#, Yan XY, Li YJ, Liu ZM, Lu ZH, Jia ZW. Epidemics of HIV Infection among Heavy Drug Users of Depressants Only, Stimulants Only, and Both Depressants and Stimulants in Mainland China: A Series, Cross-Sectional Studies. International Journal of Environmental Research and Public Health. 2020 Jul 29;17(15):5483. doi: 10.3390/ijerph17155483.

6. Zhang B#, Lu Z, Wang L, et al. Tracking HIV infection and networks of drugs users in China: a national series, cross-sectional study. Lancet, 2018, 392. doi:10.1016/s0140-6736(18)32677-1.

7. Yan X, Qin Si, Zhang B*. Take action to mitigate the impact of the COVID-19 pandemic on HIV prevention and control. Lancet Reg Health West Pac. 2023 Apr 10;36:100767. doi: 10.1016/j.lanwpc.2023.100767

8. Lei Wang, Xiangyu Yan, Lin Mei, Zhongwei Jia, Bo Zhang*. Effect of e-health interventions on HIV prevention: a protocol of systematic review and meta-analysis. Syst Rev. 2023 Jun 30;12(1):106. doi: 10.1186/s13643-023-02274-6

9. Yan X, Wang X, Wang L, Zhang B*, Jia Z. Refocus attention on HIV/AIDS: it was neglected during the COVID-19 pandemic. Clinical Microbiology and Infection. 2022 Jun 18:S1198-743X(22)00324-X. doi: 10.1016/j.cmi.2022.06.011.

10. Yan X, Jia Z, Zhang B*. Evaluating the risk compensation of HIV/AIDS prevention measures. Lancet Infectious Diseases. 2022 Apr;22(4):447-448. doi: 10.1016/S1473-3099(22)00151-7.

11. Yan X, Fang Y, Li Y, Jia Z, Zhang B*. Risks, Epidemics, and Prevention Measures of Infectious Diseases in Major Sports Events: Scoping Review. JMIR Public Health Surveill. 2022 Dec 2;8(12):e40042. doi: 10.2196/40042.

12. Wang X, Cai Y, Zhang B*, Zhang X, Wang L, Yan X, Zhao M, Zhang Y*, Jia Z. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition. Infectious Diseases of Poverty. 2022 Mar 18;11(1):32. doi: 10.1186/s40249-022-00955-3.

13. Yan X, Xiao W, Zhou S, Wang X, Wang Z, Zhao M, Li T, Jia Z, Zhang B*, Shui T*. A four-generation family transmission chain of COVID-19 along the China-Myanmar border in October to November 2021. Front Public Health. 2022 Nov 17;10:1004817. doi: 10.3389/fpubh.2022.1004817.

14. Zhang P, Yan XY, Li YJ, Zhang B*, Wang J*. CD4+ T Cell Recovery among Patients with HIV/AIDS who Received Highly Active Antiretroviral Therapy Regularly in Chongqing, China: An Ambispective Cohort Study. Biomedical and Environmental Sciences. 2022 Mar 20;35(3):254-258. doi: 10.3967/bes2022.035.

15. Yan X, Chang L, Wang Z, Hao L, Jia Z, Zhang B*, Shui T*. Exploring the Bridge Cases' Role in the Transmission of the SARS-CoV-2 Delta Variant - Ruili City, Yunnan Province, China, July-September 2021. China CDC Weekly. 2021 Dec 3;3(50):1065-1070. doi: 10.46234/ccdcw2021.239

16. Yan X, Wang X, Zhang X, Wang L, Zhang B*, Jia Z*. The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China. Frontiers in Public Health. 2021 Dec 16;9:737817. doi: 10.3389/fpubh.2021.737817.

17. Li Y, Yan X, Zhang B, Wang Z, Su H, Jia Z. A Method for Detecting and Analyzing Facial Features of People with Drug Use Disorders. Diagnostics (Basel). 2021 Aug 28;11(9):1562. doi: 10.3390/diagnostics11091562.

18. Li Y, Yan X, Wang Z, Zhang B, Jia Z. Clear the fog of negative emotions: A new challenge for intervention towards drug users. Journal of Affective Disorders. 2021 Nov 1;294:305-313. doi: 10.1016/j.jad.2021.07.029.

19. Yan X, Xu H, Li Y, Su H, Zhang B, Jia Z. Clustering HIV infections among MSM fuelled by drug and internet. Sexually Transmitted Infections. 2022 Mar;98(2):153. doi: 10.1136/sextrans-2021-054982.

20. Yan X, Su H, Zhang B, Li Y, Zhang L, Jia Z. Adherence of HIV Self-Testing Among Men Who Have Sex With Men in China: Longitudinal Study. Journal of Medical Internet Research. 2020 Sep 17;22(9):e19627. doi: 10.2196/19627.

21. Yan X, Li Y, Su H, Xing Y, Zhang B, Lu Z, Jia Z. Protect MSM from HIV and other sexually transmitted diseases by providing mobile health services of partner notification: protocol for a pragmatic stepped wedge cluster randomized controlled trial. BMC Public Health. 2020 Jul 14;20(1):1107. doi: 10.1186/s12889-020-09162-x.

22. Yan X, Lu Z, Zhang B, Li Y, Tang W, Zhang L, Jia Z. Protecting Men Who Have Sex With Men From HIV Infection With an mHealth App for Partner Notification: Observational Study. JMIR mHealth and uHealth. 2020 Feb 19;8(2):e14457. doi: 10.2196/14457.

23. Li Y, Yan X, Wang Z, Ma M, Zhang B, Jia Z. Comparison of the Users' Attitudes Toward Cannabidiol on Social Media Platforms: Topic Modeling Study. JMIR Public Health Surveill. 2023 Jan 11;9:e34132. doi: 10.2196/34132.

24. Bo Zhang#, Xiangyu Yan, Zhongwei Jia. Network fuel HIV transmission among people who inject drugs. The 6th National Conference on HIV/AIDS[C]. 2019.

25. 闫翔宇，张波，贾忠伟. ARIMA模型在我国性传播HIV/AIDS新发病例数变化趋势预测中的应用[C]. 2019.

26. 张波，闫翔宇. 京津冀地区毒品流行现状、趋势及对策研究. 北大首都智库2019(2).

27. 张波，闫翔宇，贾忠伟. 京津冀地区主要毒品流行现状及毒情治理研究. 北京大学首都发展新年论坛2019.

28. 张波，闫翔宇，贾忠伟. 阿片类毒品使用者HIV感染影响因素及吸毒网络特征分析. 山东大学大学公共卫生博士研究生学术论坛2018.

29. 张波，闫翔宇，张翔宇，贾忠伟. 老年人麻醉药品和精神药品滥用现状及预防策略研究进展. 中华流行病学杂志, 2020(04): 615-620.

30. 闫翔宇，王雪纯，李永杰，王泽昆，张波，贾忠伟. 潜在狄利克雷分布模型在医学研究中的应用. 现代预防医学. 2021.

31. 闫翔宇，苏鹤轩，张波，贾忠伟. 阶梯整群随机对照试验的样本量和功效计算方法.现代预防医学, 2019, 46(23): 4229-4232.

32. 贾忠伟，陆祖宏，范文勇，哈鹰，张波，赵海清，张志娟，赵岚岚.基于互联网+和人工智能技术的吸毒人员公共卫生管理模式研究. 系统科学与数学.2019:39（4）:1-12.

33. 尹诗琪，闫翔宇，苏鹤轩，张波.基于ARIMA模型预测性传播HIV/AIDS新发现病例数变化趋势[J].中国艾滋病性病,2020,26(07):709-713.DOI:10.13419/j.cnki.aids.2020.07.09.

【专利和著作权】

1. 发明专利：贾忠伟, 陆祖宏, 闫翔宇, 陈露, 张波. 男男性行为人群的健康促进方法和系统（专利号：CN109345077A）

2. 实用新型专利：胡建英,税铁军,苏秋东,康文玉,唐婷婷,闫翔宇,张波,凌阅微. 一种乙型肝炎病毒核酸检测用的恒温加热箱（已受理，2024S4749）

3. 软件著作权：张波. 大型体育赛事传染病风险分析与应对方案信息系统(2022SR0386930)